Concepedia

Jennifer L. Davis

JL

Statistics

Publications

29

Citations

1.2K

H-Index

22

Active since

1972

Affiliations

Washington University in St. Louis(Current)

University of California, Berkeley

National Institutes of Health

Shriners Hospitals for Children - St. Louis

Johns Hopkins University

Jennifer L. Davis is an author at Washington University in St. Louis specializing in life sciences, medicine, and oncology.

ORCID

Publications per year

1972–2023

29

Publications

29

A presumptive helicase (MOT1 gene product) affects gene expression and is required for viability in the yeast Saccharomyces cerevisiae.

Jennifer L. Davis, Riyo Kunisawa, Jeremy Thorner · Molecular and Cellular Biology · 1992 · 164 citations · Full text

, , +14

Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers

John T. Vetto, Sharon S. Lum, Arden M. Morris et al. · The American Journal of Surgery · 1997 · 121 citations

, , +15

Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment

Xinming Su, Yalin Xu, Gregory C. Fox et al. · Journal of Clinical Investigation · 2021 · 114 citations · Full text

, , +17

Characterization of a cDNA clone encoding the visna virus transactivating protein.

Jennifer L. Davis, Judith Clements · Proceedings of the National Academy of Sciences · 1989 · 63 citations · Full text

, , +16

Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector

Lisa Tsui, Michael T. Kelly, Nathalie Zayek et al. · Nature Biotechnology · 2002 · 62 citations

, , +13

1–5 of 29